pSivida Announces Positive Results from the Two Phase 3 FAME Trials of Iluvien in Patients with Diabetic Macular Edema-Conference Call
http://www.earnings.com/conferencecallhost.asp?event=2640024&client=cb
:)
Add to My Watchlist
What is My Watchlist?